APPLICATION OF AASM CLINICAL SIGNIFICANCE THRESHOLDS TO ONCE-NIGHTLY SODIUM OXYBATE FOR IMPROVEMENT IN NARCOLEPSY SYMPTOMS

被引：0
|
作者：
Roth, Thomas [1 ]
Thorpy, Michael [2 ]
Kushida, Clete [3 ]
Morse, Anne [4 ]
Dubow, Jordan [5 ]
Gudeman, Jennifer [5 ]
Dauvilliers, Yves [6 ]
机构：
[1] HenryFord Hosp, Detroit, MI USA
[2] MontefioreMed Ctr, Bronx, NY USA
[3] Stanford Univ, Sch Med, Stanford, CA USA
[4] Geisinger Commonwealth Sch Med, Scranton, PA USA
[5] Avadel Pharmaceut, Dublin, Ireland
[6] Univ Montpellier, Gui de Chauliac Hosp, Natl Reference Ctr Orphan Dis, CHU Montpellier,INMINSERM, Montpellier, France
来源：
SLEEP | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
0573
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [1] APPLICATION OF AASM CLINICAL SIGNIFICANCE THRESHOLDS TO ONCE-NIGHTLY SODIUM OXYBATE FOR IMPROVEMENT IN NARCOLEPSY SYMPTOMS
    Roth, T.
    Thorpy, M. J.
    Kushida, C. A.
    Morse, A. M.
    Dubow, J.
    Gudeman, J.
    Dauvilliers, Y.
    SLEEP MEDICINE, 2024, 115 : 205 - 206
  • [2] COMPOSITE RESPONSE WITH ONCE-NIGHTLY SODIUM OXYBATE: SYMPTOM IMPROVEMENT IN PARTICIPANTS WITH NARCOLEPSY TYPE 1
    Ortiz, Luis
    Roth, Thomas
    Morse, Anne
    Thorpy, Michael
    Harsh, John
    Kushida, Clete
    Gudeman, Jennifer
    Dauvilliers, Yves
    SLEEP, 2024, 47
  • [3] Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy
    Kushida, Clete A.
    Shapiro, Colin M.
    Roth, Thomas
    Thorpy, Michael J.
    Corser, Bruce C.
    Ajayi, Akinyemi O.
    Rosenberg, Russell
    Roy, Asim
    Seiden, David
    Dubow, Jordan
    Dauvilliers, Yves
    SLEEP, 2022, 45 (06)
  • [4] COMPOSITE RESPONSE WITH ONCE-NIGHTLY SODIUM OXYBATE: SYMPTOM IMPROVEMENT IN PARTICIPANTS WITH NARCOLEPSY TYPE 1 IN REST-ON
    Ortiz, L. E.
    Roth, T.
    Morse, A. M.
    Thorpy, M. J.
    Harsh, J.
    Kushida, C. A.
    Dubow, J.
    Gudeman, J.
    Dauvilliers, Y.
    SLEEP MEDICINE, 2024, 115 : 210 - 211
  • [5] Once-nightly sodium oxybate (FT218) improved symptoms in people with narcolepsy: a plain language summary of publication
    Kushida, Clete A.
    Thorpy, Michael J.
    Flygare, Julie
    Roy, Asim
    Dubow, Jordan
    Seiden, David
    FUTURE NEUROLOGY, 2022, 17 (05)
  • [6] ASSESSING USABILITY OF ONCE-NIGHTLY SODIUM OXYBATE EXTENDED-RELEASE ORAL SUSPENSION FOR NARCOLEPSY
    Lavender, Maggie
    Wermter, Ellen
    Ortiz, Luis
    Morse, Anne
    Horsnell, Matthew
    Gudeman, Jennifer
    SLEEP, 2024, 47 : A272 - A272
  • [7] LONG-TERM SAFETY AND EFFICACY OF EXTENDED-RELEASE ONCE-NIGHTLY SODIUM OXYBATE FOR NARCOLEPSY
    Corser, B. C.
    Morse, A. M.
    Stern, T.
    Ajayi, A. O.
    Kushida, C. A.
    Gudeman, J.
    SLEEP MEDICINE, 2024, 115 : 220 - 220
  • [8] Pharmacokinetics and Formulation Selection of FT218, a Once-Nightly Sodium Oxybate Formulation for the Treatment of Narcolepsy
    Dubow, Jordan
    Monteith, David
    Grassot, Julien
    Seiden, David
    NEUROLOGY, 2020, 94 (15)
  • [9] Pharmacokinetics and Dose Proportionality of FT218, a Once-Nightly Sodium Oxybate Formulation for the Treatment of Narcolepsy
    Dubow, Jordan
    Grassot, Julien
    Monteith, David
    Seiden, David
    NEUROLOGY, 2020, 94 (15)
  • [10] Long-Term Safety of Once-Nightly Sodium Oxybate for Narcolepsy: RESTORE Study Interim Analysis of Data
    Stern, Thomas
    Roy, Asim
    Shapiro, Colin M.
    Harsh, John
    Ajayi, Akinyemi O.
    Ibrahim, Sally
    Dubow, Jordan
    Gudeman, Jennifer
    ANNALS OF NEUROLOGY, 2023, 94 : S268 - S268
12345